PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinoma.
PRMT5抑制剂可积极促进肺腺癌的转移进展。
期刊:
影响因子:
doi:10.64898/2026.01.30.702866
Fowler Colin E, O'Hearn Natalie A, Henning Nicole, Griffen Anthony, Mathey-Andrews Nicolas, Salus Griffin J, Hazan Renin, Jacks Tyler, Burds Aurora A, Mueller Helen S, Soto-Feliciano Yadira, LaFave Lindsay M, Lees Jacqueline A